Sarah Donald

951 total citations
34 papers, 679 citations indexed

About

Sarah Donald is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sarah Donald has authored 34 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 6 papers in Molecular Biology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sarah Donald's work include Botulinum Toxin and Related Neurological Disorders (7 papers), Neurological disorders and treatments (7 papers) and Pregnancy and Medication Impact (4 papers). Sarah Donald is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (7 papers), Neurological disorders and treatments (7 papers) and Pregnancy and Medication Impact (4 papers). Sarah Donald collaborates with scholars based in United Kingdom, New Zealand and United States. Sarah Donald's co-authors include Heidi C. E. Welch, Karen E. Anderson, Daniel T. Patton, Campbell D. Lawson, W. John Coadwell, Simon Andrews, Simon Walker, Candice Ward, David Simmons and Richard D. Verschoyle and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Sarah Donald

32 papers receiving 669 citations

Peers

Countries citing papers authored by Sarah Donald

Since Specialization

Citations

This map shows the geographic impact of Sarah Donald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Donald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Donald more than expected).

Fields of papers citing papers by Sarah Donald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Donald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Donald. The network helps show where Sarah Donald may publish in the future.

Co-authorship network of co-authors of Sarah Donald

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Donald. A scholar is included among the top collaborators of Sarah Donald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Donald. Sarah Donald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Small for Gestational Age Coded Diagnoses in Aotearoa New Zealand's Administrative Health Datasets: A Validation Study 2025 ·Health Science Reports ·Mei‐Ling Blank, Sarah Donald, Lianne Parkin	0
2	Activity of botulinum neurotoxin X and its structure when shielded by a non-toxic non-hemagglutinin protein 2024 ·Communications Chemistry ·Markel Martínez‐Carranza, Jana Škerlová, Pyung‐Gang Lee, Jie Zhang, (unknown), Abhishek Sirohiwal, (unknown), Mark Elliott, Jules Philippe, Sarah Donald, (unknown), Linda Henriksson, Geoffrey Masuyer, Ville R. I. Kaila, Matthew Beard, Min Dong, Pål Stenmark	5
3	Evaluation of a New ‘Mix-In’ Style Glycomacropeptide-Based Protein Substitute for Food and Drinks in Patients with Phenylketonuria and Tyrosinemia 2023 ·Nutrients ·Marta Delsoglio, (unknown), Anita MacDonald, Anne Daly, Catherine Ashmore, Sarah Donald, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Gary P. Hubbard, R.J. Stratton	2
4	Evaluation of a New Glycomacropeptide-Based Protein Substitute in Powdered and Liquid Format in Patients with PKU 2023 ·Nutrients ·Marta Delsoglio, (unknown), Anita MacDonald, Anne Daly, Catherine Ashmore, (unknown), Sarah Donald, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Gary P. Hubbard, R.J. Stratton	0
5	Are women with gestational diabetes being screened for type 2 diabetes following pregnancy? A nationwide retrospective cohort study in Aotearoa New Zealand 2022 ·Diabetes Research and Clinical Practice ·(unknown), Sarah Donald, Kirsten J. Coppell, (unknown), Sue Crengle, Lianne Parkin	6
6	Antidepressant dispensing before, during, and after pregnancy in New Zealand, 2005‒2014 2021 ·Australian and New Zealand Journal of Obstetrics and Gynaecology ·Sarah Donald, Katrina Sharples, (unknown), Simon Horsburgh, Lianne Parkin	7
7	Prescription medicines with potential for foetal harm: dispensing before and during pregnancy in New Zealand, 2005–2015 2020 ·European Journal of Clinical Pharmacology ·Sarah Donald, Katrina Sharples, (unknown), Simon Horsburgh, Lianne Parkin	2
8	Patterns of prescription medicine dispensing before and during pregnancy in New Zealand, 2005–2015 2020 ·PLoS ONE ·Sarah Donald, Katrina Sharples, (unknown), Simon Horsburgh, Lianne Parkin	7
9	ONE AND A HALF STAGE EXCHANGE ARTHROPLASTY FOR INFECTED TOTAL KNEE ARTHROPLASTY 2020 ·(unknown), Sarah Donald, (unknown), (unknown)	3
10	Engineering an Effective Human SNAP-23 Cleaving Botulinum Neurotoxin A Variant 2020 ·Toxins ·Stefan Sikorra, Sarah Donald, Mark Elliott, (unknown), (unknown), (unknown), Vineeta Tripathi, (unknown), Matthew Beard, Thomas Binz	5
11	Generation of a pregnancy cohort for medicine utilisation and medicine safety studies in New Zealand 2018 ·Pharmacoepidemiology and Drug Safety ·Sarah Donald, (unknown), Simon Horsburgh, Katrina Sharples, Lianne Parkin	6
12	A comparison of biological activity of commercially available purified native botulinum neurotoxin serotypes A1 to F1 in vitro, ex vivo, and in vivo 2018 ·Pharmacology Research & Perspectives ·Sarah Donald, Mark Elliott, (unknown), (unknown), Agnieszka Lewandowska, (unknown), (unknown), (unknown), (unknown), Mikhail Kalinichev, Johannes Krupp, Elena Fonfría	24
13	Impact of Community Based Peer Support in Type 2 Diabetes: A Cluster Randomised Controlled Trial of Individual and/or Group Approaches 2015 ·PLoS ONE ·David Simmons, A Toby Prevost, Christopher Bunn, Daniel Holman, Richard Parker, Simon Cohn, Sarah Donald, Charlotte Paddison, Candice Ward, (unknown), Jonathan Graffy	70
14	Testing a peer support intervention for people with type 2 diabetes: a pilot for a randomised controlled trial 2013 ·BMC Family Practice ·David Simmons, Simon Cohn, Christopher Bunn, (unknown), Sarah Donald, Charlotte Paddison, Candice Ward, (unknown), A Toby Prevost, Jonathan Graffy	37
15	Successful use of acarbose to manage post-prandial glycaemia in two patients with type 1 diabetes on continuous subcutaneous insulin infusion 2011 ·Diabetes Research and Clinical Practice ·Satya Dash, Sarah Crisp, Sara Hartnell, Sarah Donald, Katy Davenport, David Simmons, Mark L. Evans	5
16	Reduced insulin requirements during participation in the DAFNE (dose adjustment for normal eating) structured education programme 2011 ·Diabetes Research and Clinical Practice ·Lalantha Leelarathna, Candice Ward, Katy Davenport, Sarah Donald, (unknown), Francis Finucane, Mark L. Evans	4
17	P-Rex1 and Vav1 Cooperate in the Regulation of Formyl-Methionyl-Leucyl-Phenylalanine–Dependent Neutrophil Responses 2010 ·The Journal of Immunology ·Campbell D. Lawson, Sarah Donald, Karen E. Anderson, Daniel T. Patton, Heidi C. E. Welch	69
18	Gastroenterology service in a teaching hospital in rural New Zealand, 1991-2003 2009 ·World Journal of Gastroenterology ·Michael Schultz, Andrew Davidson, Sarah Donald, (unknown), Angus Turnbull, (unknown), Vicki Livingstone, John D. Dockerty	3
19	Dietary agent indole‐3‐carbinol protects female rats against the hepatotoxicity of the antitumor drug ET‐743 (trabectidin) without compromising efficacy in a rat mammary carcinoma 2004 ·International Journal of Cancer ·Sarah Donald, Richard D. Verschoyle, Peter Greaves, Tina Colombo, Massimo Zucchetti, (unknown), (unknown), Maurizio D’Incalci, Margaret M. Manson, José Jimeno, William P. Steward, Andreas J. Gescher	35
20	Comparison of four modulators of drug metabolism as protectants against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the female rat and in hepatocytes in vitro 2004 ·Cancer Chemotherapy and Pharmacology ·Sarah Donald, Richard D. Verschoyle, Peter Greaves, Samantha Orr, José Jimeno, Andreas J. Gescher	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact